Insights › Medicine & pharma › November 19, 2026
Medicine & pharma · Official intelligence

Japan suspends unapproved regenerative cancer therapy at ICVS Tokyo Clinic

Japan MHLW Published:

The Japanese Ministry of Health, Labour and Welfare issued an emergency order to suspend the provision of dendritic cell and activated lymphocyte therapies for advanced cancer at ICVS Tokyo Clinic. This action enforces the Act on Securing Safety of Regenerative Medicine against unauthorized clinical use.

Original source
Read the source — mhlw.go.jp ↗

We link to the original publisher. The summary above is a short guide; read the original for the full details.

More in Medicine & pharma

See everything in Medicine & pharma →

Look into this further

Read every record in your own language

This page shows the three newest items per field. Members see every record in the field, in 109 languages, with the search engines that work on them.

Read it all — start from $3No app-store installation. Cancel any time.